Showing 109 results
-
Story / -
Media Release /NOYCIA recognizes excellence in Canadian oncology research as part of Novartis Canada’s commitment to reimagining medicineMontreal, QC, June 11, 2024 – Novartis Canada is pleased to announce the…
-
Media Release /Psoriatic arthritis is a chronic, autoimmune disease form of arthritis that causes joint inflammation (swelling, pain, stiffness) and occurs with skin condition psoriasis. It can also affect the…
-
Media Release /Approval is based on the two largest Phase III trials conducted in HS – SUNSHINE and SUNRISE – demonstrating the safety and efficacy of Cosentyx® in HS1HS is a chronic, immunological, inflammatory…
-
Media Release /More than 90,000 Canadians—or one in 400 people across Canada—live with multiple sclerosis (MS),1 a neurodegenerative, chronic condition that affects the central nervous system.2Despite decades…
-
Media Release /Montréal, QC, March 21, 2024 – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is deeply disappointed with the draft recommendations of the Canadian Drug Expert Committee (CDEC) issued by…
